Skip to content

Drug interactions

Buprenorphine + Eliglustat

Severity: Moderate

Buprenorphine and Eliglustat: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can prolong the QT interval, so using them together may add to the risk of ventricular arrhythmia including torsades de pointes. Risk rises with higher doses, electrolyte disturbances or underlying heart disease.

What this interaction means in plain words

Buprenorphine and Eliglustat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Buprenorphine belongs to Musculoskeletal; Eliglustat belongs to Miscellaneous.

Evidence level: Low

Why it happens

Additive QTc prolongation through pharmacodynamic effects on cardiac repolarization.

What to do

Obtain a baseline ECG and monitor QTc during combined use, correcting potassium and magnesium. Consider an alternative if QTc becomes markedly prolonged or the patient has other risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine and Eliglustat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine with Eliglustat?

MediHelp rates the interaction as moderate. Buprenorphine and Eliglustat can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can prolong the QT interval, so using them together may add to the risk of ventricular arrhythmia including torsades de pointes. Risk rises with higher doses, electrolyte disturbances or underlying heart disease.

How serious is the interaction between Buprenorphine and Eliglustat?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and monitor QTc during combined use, correcting potassium and magnesium. Consider an alternative if QTc becomes markedly prolonged or the patient has other risk factors.

What other medicines interact with Buprenorphine?

MediHelp also lists interactions of Buprenorphine with, for example, Alvimopan, Calcium / magnesium / potassium / sodium oxybates, Olanzapine / samidorphan. The full list is on the Buprenorphine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in